BSE filing, NSE: ARAVALISEC. Summary written from the filing by ALFA Finder's alert engine.
Aravali Securities & Finance Ltd: key numbers
- Share price
- ₹3.33
- Market cap
- ₹5.05 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.18 Cr
- P/E (TTM)
- -28.3×Sector 19.7×
- Promoter holding
- 54.56%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aravali Securities & Finance Ltd
All →Aravali Securities & Finance Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Widens
Aravali Securities & Finance Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Aravali Securities & Finance Board Meeting Date
Aravali Securities & Finance Ltd will hold a board meeting on August 12, 2026, to consider un-audited financial results for the quarter ended June 30, 2026.
Aravali Securities & Finance Annual General Meeting
Aravali Securities & Finance Ltd held its 46th AGM on July 4, 2026. Resolutions on financial statements and director appointments were passed with requisite majority.
Aravali Securities & Finance Annual Report
Aravali Securities & Finance Limited has released its Integrated Annual Report for FY 2025-26. The 46th AGM is scheduled for July 04, 2026.
Aravali Securities & Finance Annual General Meeting
Aravali Securities & Finance scheduled its 46th AGM for July 04, 2026, via video conferencing. The company also announced e-voting dates and the closure of its register.
Aravali Securities & Finance Board Meeting Outcome
Aravali Securities approved the re-appointment of internal auditors and recommended director appointments. The board also authorized convening the 46th Annual General Meeting.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.